75
Participants
Start Date
September 18, 2019
Primary Completion Date
July 31, 2025
Study Completion Date
October 31, 2025
ferumoxytol
Each 20 mL single-use vial contains 17 mL of ferumoxytol that consists of iron at a concentration of 30 mg Fe/mL, coated with polyglucose sorbitol carboxymethylether and formulated with mannitol, at a concentration of 44 mg/mL, in a black to reddish brown sterile, aqueous, colloidal, isotonic solution
Iron sucrose
Each mL contains 20 mg of elemental iron as iron sucrose in water for injection. The 5 mL single-use vial contains 100 mg of iron per 5 mL. The drug product contains approximately 30% sucrose (300 mg/mL).
NOT_YET_RECRUITING
Gwinnett Research Institute, Buford
NOT_YET_RECRUITING
University of Florida, Gainesville
RECRUITING
Optimus U Corporation, Miami
RECRUITING
Biomedical Research LLC, Miami
NOT_YET_RECRUITING
Arkansas Children's Hospital, Little Rock
RECRUITING
Sun Research Institute, San Antonio
NOT_YET_RECRUITING
JSC Saules seimos medicinos centras, Kaunas
NOT_YET_RECRUITING
Klaipeda Children's Hospital, Klaipėda
NOT_YET_RECRUITING
Children's Hospital-Affiliate of Vilnius University Hospital Santariskiu Klinikos, Vilnius
NOT_YET_RECRUITING
Osrodek Badan Klinicznych In Vivo sp. z o.o., Bydgoszcz
NOT_YET_RECRUITING
Prywatny Gabinet Lekarski Dr N. med. Jerzy Brzostek, Dębica
NOT_YET_RECRUITING
Pro Familia Altera Sp. z o.o., Katowice
NOT_YET_RECRUITING
Korczowski Bartosz, Gabinet Lekarski, Rzeszów
NOT_YET_RECRUITING
Centrum Zdrowia MDM, Warsaw
NOT_YET_RECRUITING
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw
Lead Sponsor
AMAG Pharmaceuticals, Inc.
INDUSTRY